Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: Experience at a single, large care center

37Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Aim: To assess outcomes among patients with Duchenne muscular dystrophy receiving deflazacort or prednisone in real-world practice. Methods: Clinical data for 435 boys with Duchenne muscular dystrophy from Cincinnati Children's Hospital Medical Center were studied retrospectively using time-to-event and regression analyses. Results: Median ages at loss of ambulation were 15.6 and 13.5 years among deflazacort- and prednisone-initiated patients, respectively. Deflazacort was also associated with a lower risk of scoliosis and better ambulatory function, greater % lean body mass, shorter stature and lower weight, after adjusting for age and steroid duration. No differences were observed in whole body bone mineral density or left ventricular ejection fraction. Conclusion: This single center study adds to the real-world evidence associating deflazacort with improved clinical outcomes.

References Powered by Scopus

NF-κB signaling in inflammation

6240Citations
N/AReaders
Get full text

Dystrophin: The protein product of the duchenne muscular dystrophy locus

3971Citations
N/AReaders
Get full text

Survival in Duchenne muscular dystrophy: Improvements in life expectancy since 1967 and the impact of home nocturnal ventilation

809Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

56Citations
N/AReaders
Get full text

Natural History and Real-World Data in Rare Diseases: Applications, Limitations, and Future Perspectives

51Citations
N/AReaders
Get full text

Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Marden, J. R., Freimark, J., Yao, Z., Signorovitch, J., Tian, C., & Wong, B. L. (2020). Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: Experience at a single, large care center. Journal of Comparative Effectiveness Research, 9(3), 177–189. https://doi.org/10.2217/cer-2019-0170

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

53%

Professor / Associate Prof. 5

26%

Researcher 3

16%

Lecturer / Post doc 1

5%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

37%

Biochemistry, Genetics and Molecular Bi... 6

32%

Neuroscience 4

21%

Chemistry 2

11%

Article Metrics

Tooltip
Mentions
News Mentions: 13

Save time finding and organizing research with Mendeley

Sign up for free